Latest News & Features
Americas
Judges at Munich Local Division determined that Meril infringed Edwards Lifesciences’ patent | Meril ordered to stop selling and recall product as well as pay damages. 19 November 2024
Americas
US Supreme Court blocks bid to overturn lower court ruling | District court found in 2023 that the generic would infringe patents owned by a Bausch subsidiary | Blockbuster drug Xifaxan is used to treat IBS with diarrhoea, and a liver-related brain disorder. 19 November 2024
Americas
Vidal to return to Silicon Valley litigation department and advise on AI issues | Firm is ‘thrilled to welcome Kathi back’ and looking forward to benefitting from her leadership expertise. 19 November 2024
Europe
European patent related to an inhaler revoked following successful appeal by GSK | Ruling comes after a series of challenges over novelty and inventive step | Decision further intensifies ongoing patent disputes between the pharma giants. 14 November 2024
Americas
Michael Summersgill and his co-counsel at WilmerHale secured more favourable outcomes for their clients than others in a series of lawsuits brought by Ravgen over pre-natal screening tests, he tells Sarah Speight. 14 November 2024
Americas
Board elected new president and officers at this year’s Leadership Meeting in New Orleans | Details released on updates to trademark law guidelines and new Think Tank. 14 November 2024
Americas
Vidal announced she will return to private sector after December departure | USPTO director told colleagues they had “transformed” the agency during her time there. 14 November 2024
Europe
Transatlantic deal would make ‘HSF Kramer’ a top 20 global firm by revenue | ‘Transformational’ combination a ‘one-of-a-kind’ opportunity, say firms’ leaders | HSF Kramer would have 2,700 lawyers, including 640 partners across 25 offices | IP practice would have approximately 32 partners. 14 November 2024
Americas
Oral arguments heard in case between Teva and generics maker Amneal over inhaler patents | Teva says district court and Amneal asked court to ‘slice apart new drug application’. 12 November 2024
Europe
The patents have been officially revoked following the pair's voluntary decision to withdraw them | Withdrawal follows unfavourable preliminary opinion from the EPO | Cancelled patents not expected to impact ongoing licensing agreements for CRISPR technology, says licensor. 12 November 2024